IMU Biosciences Secures $53M to Advance Immune Tech
IMU Biosciences secures over $53M to expand its immune data platform and transform disease diagnosis and treatment.
America Forever Bytes
Company
IMU Biosciences secures over $53M to expand its immune data platform and transform disease diagnosis and treatment.